On first glance, Globus Medical (GMED)
looks like it could be one of the unicorns of the med-tech space - a
legit growth story that the market hasn't already pushed up to a red-hot
valuation. Globus has what seems to be a sustainable culture built
around product innovation, and that steady stream of innovative products
could be just the ticket for success in a price-constrained implant
world. That said, valuation isn't quite the slam-dunk that value
investors may hope to see.
Please read more here:
Globus Medical Has The Growth, But What About Value?
No comments:
Post a Comment